Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 11, 2022 15:55 ET | Source: Release Co,. Ltd.

The Release Project transforms agricultural and fisheries logistics around the world with cutting-edge technologies such as AI, big data, Web3 smart contracts, and blockchain!

Yakuin, Chuo-ku Fukuoka-shi, Japan, July 11, 2022 (GLOBE NEWSWIRE) -- From Asia to the world using cutting-edge technology! Release Social Commerce is an application that uses cutting-edge...
July 05, 2022 09:15 ET | Source: Sanara MedTech Inc.

Sanara MedTech Inc. Announces Closing of Scendia Biologics, LLC Acquisition

FORT WORTH, TX, July 05, 2022 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. Based in Fort Worth, Texas, Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (NASDAQ: SMTI), a provider of...
June 27, 2022 07:30 ET | Source: Aptose Biosciences, Inc.

Aptose Appoints Fletcher Payne as Senior Vice President, Chief Financial Officer

SAN DIEGO and TORONTO, June 27, 2022 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly...
June 27, 2022 05:58 ET | Source: Research and Markets

United States Human Vaccines Market Report 2022: A Market Poised to Grow by $31.51 Bn by 2028 Featuring Sanofi Pasteur, Merck, Pfizer, Seqirus, AstraZeneca, Dynavax Technology, Emergent BioSolutions

Dublin, June 27, 2022 (GLOBE NEWSWIRE) -- The "United States Human Vaccines Market Size, Share, Top 45 Human Vaccines Brand In-depth Analysis, Emerging Trends, Current Analysis, Growth, Demand,...
June 24, 2022 12:00 ET | Source: VALNEVA

Valneva reçoit une autorisation de mise sur le marché en Europe pour son vaccin inactivé à virus entier contre la COVID-19, VLA2001

VLA2001 devient le premier vaccin contre la COVID-19 à recevoir une autorisation de mise sur le marché de type standard en Europe. Saint Herblain (France), 24 juin 2022 – Valneva SE (Nasdaq : VALN ;...
June 24, 2022 12:00 ET | Source: VALNEVA

Valneva Receives Marketing Authorization in Europe for Inactivated Whole-Virus COVID-19 Vaccine VLA2001

VLA2001 becomes the first COVID-19 vaccine to receive a standard marketing authorization in Europe Saint Herblain (France), June 24, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a...
June 23, 2022 09:20 ET | Source: Global Tech Industries Group, Inc.

Global Tech Industries Group, Inc. Requests Review of Market Making Activity

New York, NY, June 23, 2022 (GLOBE NEWSWIRE) -- Global Tech Industries Group, Inc. (OTCQB: GTII) (“GTII” or the “Company”), www.gtii-us.com, a Nevada corporation, announced today that that it has...
June 23, 2022 09:16 ET | Source: VALNEVA

Valneva reçoit un avis positif du CHMP pour une autorisation de mise sur le marché en Europe de son candidat vaccin inactivé contre la COVID-19

Saint Herblain (France), 23 juin 2022 – Valneva SE (Nasdaq : VALN ; Euronext Paris : VLA), société spécialisée dans les vaccins, annonce aujourd'hui que le Comité des médicaments à usage humain (CHMP)...
June 23, 2022 09:16 ET | Source: VALNEVA

Valneva Receives Positive CHMP Opinion for Marketing Authorization of its Inactivated COVID-19 Vaccine Candidate in Europe

Saint Herblain (France), June 23, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of...
June 15, 2022 11:45 ET | Source: VALNEVA

Valneva Announces Settlement Agreement with the UK Government

Saint-Herblain (France), June 15, 2022 – Valneva SE, (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has entered into a settlement agreement with the...